Shares of TransThera Sciences, a biotech firm with 121 employees and no revenue, have surged from HK$13.15 in June to HK$679.50 on Tuesday—an increase of more than 5,000%—stoking fears of an overheated Chinese healthcare market and a potential investment bubble.
What do you think?
“I’m always in the market to lose to money.”
“Biotech is risky, but so was building the Great Wall, and that only collapsed a few times.”
“Geez, sounds worrisome. But, honestly? Anything to take my mind off Evergrande.”
Ka Fai Wong, 66
Scroll Loyalist
Mei Lin Chan, 39
Calligraphy Judge
Chun Hei Lau, 53
Xin Dynasty Truther
Got a tip? Contact us at cds@chinadailyshow.net
Follow this and other leading China news at @chinadailyshow on Twitter